Cargando…
Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts
The Cancer Genome Atlas (TCGA) provides a genetic characterization of more than ten thousand tumors, enabling the discovery of novel driver mutations, molecular subtypes, and enticing drug targets across many histologies. Here we investigated why some mutations are common in particular cancer types...
Autores principales: | Wang, Victor G., Kim, Hyunsoo, Chuang, Jeffrey H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169918/ https://www.ncbi.nlm.nih.gov/pubmed/30281678 http://dx.doi.org/10.1371/journal.pone.0204912 |
Ejemplares similares
-
Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling
por: Zhang, Guoqiang, et al.
Publicado: (2015) -
Comparison of Mendeliome exome capture kits for use in clinical diagnostics
por: Pengelly, Reuben J., et al.
Publicado: (2020) -
Whole exome capture in solution with 3 Gbp of data
por: Bainbridge, Matthew N, et al.
Publicado: (2010) -
Comparison of somatic mutation calling methods in amplicon and whole exome sequence data
por: Xu, Huilei, et al.
Publicado: (2014) -
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
por: Bailey, Matthew H., et al.
Publicado: (2020)